Study of CD200 Activation Receptor Ligand (CD200AR-L) and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE1
Clinical Trials Related to Glioblastoma
Related studies linked through entity extraction aliases.
Early Integration of Palliative Care Using the BEACON PROQOL in Patients With High Grade Glioma and Their Caregivers
- Status
- COMPLETED
- Phase
- NA
A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
- Status
- RECRUITING
- Phase
- PHASE2
Study of Pamiparib in Newly Diagnosed and rGBM
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Safety of IMRT Treatment With Inhomogeneous Dose in Patients With Relapsed High-grade Gliomas.
- Status
- COMPLETED
- Phase
- NA
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
- Status
- TERMINATED
- Phase
- PHASE1
Surgical Nivolumab And Ipilimumab For Recurrent GBM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
- Status
- COMPLETED
- Phase
- NA
EAP for the Treatment of Glioblastoma With PVSRIPO
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
MR-guided LITT Therapy in Patients With Primary Irresectable Glioblastoma
- Status
- COMPLETED
- Phase
- NA
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Neoadjuvant PD-1 in Newly Diagnosed Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
Evaluation of the Predictive Value of 18F-fluorodeoxyglucose Positron Emission Tomography and Brain Perfusion Computed Tomography for the Efficacy of Anti-angiogenic Therapy (Bevacizumab) in Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- NA
Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma
- Status
- RECRUITING
- Phase
- PHASE1
A Trail of Fluzoparil in Combination With Temozolomide in Patients With Recurrent Glioblastoma
- Status
- UNKNOWN
- Phase
- PHASE2
Dendritic Cell Vaccination With Standard Postoperative Chemoradiation for the Treatment of Adult Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1